42:I[185,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0jo3du-icy6v2.js","/_next/static/chunks/15cy49d~_zsjj.js","/_next/static/chunks/0..ktetnpeix7.js","/_next/static/chunks/0_htf5~kl..m1.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"SendEmailButton"] 44:I[63625,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0jo3du-icy6v2.js","/_next/static/chunks/15cy49d~_zsjj.js","/_next/static/chunks/0..ktetnpeix7.js","/_next/static/chunks/0_htf5~kl..m1.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"AddToLibraryButton"] 45:I[29721,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0jo3du-icy6v2.js","/_next/static/chunks/15cy49d~_zsjj.js","/_next/static/chunks/0..ktetnpeix7.js","/_next/static/chunks/0_htf5~kl..m1.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"ShareButton"] 46:I[58016,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0jo3du-icy6v2.js","/_next/static/chunks/15cy49d~_zsjj.js","/_next/static/chunks/0..ktetnpeix7.js","/_next/static/chunks/0_htf5~kl..m1.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"ProcessEpisodeButton"] 47:I[45269,["/_next/static/chunks/08z4tkzvltetr.js","/_next/static/chunks/121~yigv24_j6.js","/_next/static/chunks/0jo3du-icy6v2.js","/_next/static/chunks/15cy49d~_zsjj.js","/_next/static/chunks/0..ktetnpeix7.js","/_next/static/chunks/0_htf5~kl..m1.js","/_next/static/chunks/0i6hzvr84kc1r.js"],"SignupCTA"] 3a:["$","h1",null,{"className":"max-w-[22ch] font-display text-[clamp(32px,4.5vw,48px)] font-medium leading-[1.05] tracking-[-0.02em] text-[color:var(--fg-1)] text-balance","children":"EP 289 - David Matthews - Mastering Mass Torts and Winning High-Profile Cases"}] 3b:["$","div",null,{"className":"flex flex-wrap items-center gap-x-4 gap-y-1 font-mono text-[12px] uppercase tracking-[0.1em] text-[color:var(--fg-3)]","children":[["$","time",null,{"dateTime":"2024-10-25T11:00:02.000Z","children":"October 25, 2024"}],["$","span",null,{"aria-hidden":true,"children":"·"}],["$","span",null,{"children":"00:33:21"}],false]}] 3c:["$","p",null,{"className":"max-w-[60ch] text-[18px] leading-[1.5] text-[color:var(--fg-2)]","children":"David Matthews is the Firm Founder of Matthews and Associates. \n\nDavid has been chosen through US News & World Report as one of the Best Lawyers in America from 2016-2023 and repeatedly voted by his peers as one of the top trial lawyers in the..."}] 43:T40a,David Matthews is the Firm Founder of Matthews and Associates.

David has been chosen through US News & World Report as one of the Best Lawyers in America from 2016-2023 and repeatedly voted by his peers as one of the top trial lawyers in the country.

He has tried more than 175 cases to verdict and helped injured people across the country attain some of the largest verdicts or settlements in pharmaceutical litigation against the makers of such drugs as Phen-Fen, Rezulin, Vioxx, and Bextra-Celebrex.

Connect with David on LinkedIn: https://www.linkedin.com/in/david-matthews-a3a51811b/

Visit Matthews and Associates: https://www.thewagstafflawfirm.com/

On This Episode, We Discuss…

How the Landscape of Mass Tort Litigation has Evolved Over the Years
Complexities of Pharmaceutical Litigation
Strategic Elements of Mass Tort Litigation
Camp Lejeune Water Contamination Case